Business

Novo Nordisk Initiates U.S. Layoffs Amid Global Restructuring, Sources Confirm

Pharmaceutical giant Novo Nordisk has commenced a significant round of layoffs in the United States, its most crucial market, according to internal communications and sources familiar with the matter. The job reductions span numerous departments including regulatory affairs, sales, and clinical development as part of a broader global restructuring initiative. The layoffs come as new CEO Mike Doustdar aims to restore investor confidence amid competitive pressures.

U.S. Workforce Reductions Underway

Novo Nordisk has initiated a substantial round of layoffs in the United States, according to reports from internal company communications and sources familiar with the situation. The Danish pharmaceutical company, known for its popular weight-loss medication Wegovy, reportedly began notifying affected U.S. employees this week, with the process expected to continue through late next week.

Assistive TechnologyBusiness Software

German State Adopts Open-Source Email for Digital Sovereignty

The German state of Schleswig-Holstein has completed a six-month migration from Microsoft Exchange and Outlook to open-source alternatives. This strategic move toward digital sovereignty covers 40,000 mailboxes and over 100 million messages. The transition represents a significant step in reducing dependence on large tech corporations.

Major Open-Source Migration Completed

The German state of Schleswig-Holstein has successfully transitioned from proprietary Microsoft systems to open-source solutions for government email and calendar functions. This comprehensive six-month migration replaced Microsoft Exchange and Outlook with Open-Xchange and Mozilla Thunderbird, covering more than 40,000 mailboxes and over 100 million messages and calendar entries.